| Product NDC: | 52544-733 |
| Proprietary Name: | Dilacor |
| Non Proprietary Name: | diltiazem hydrochloride |
| Active Ingredient(s): | 180 mg/1 & nbsp; diltiazem hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52544-733 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020092 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19920529 |
| Package NDC: | 52544-733-10 |
| Package Description: | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52544-733-10) |
| NDC Code | 52544-733-10 |
| Proprietary Name | Dilacor |
| Package Description | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52544-733-10) |
| Product NDC | 52544-733 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diltiazem hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19920529 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Strength Number | 180 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |